PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Iobenguane→

Iobenguane PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
77679-27-7
Molecular formula
C8H10IN3
Molecular weight
275.09 g/mol
Drug class
Norepinephrine analogueadrenergic-neuron blocking agent and radiopharmaceutical imaging precursor
Mechanism of action
Taken up by the norepinephrine transporter in adrenergic nerve terminals and stored in presynaptic vesicles, with accumulation in adrenergically innervated tissues and neural-crest-derived tumours. When radiolabelled with iodine-123 or iodine-131, it enables diagnostic imaging or targeted radiotherapy.
Indications / reported uses
  • Diagnostic imaging of pheochromocytoma, neuroblastoma and selected other adrenergic tumours with iodine-123-labelled iobenguane.
  • Targeted radiotherapy of selected unresectable or metastatic pheochromocytoma/paraganglioma with iodine-131-labelled iobenguane, where authorised.

Sources: https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane · https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c89d3ecc-4f4c-4566-8808-79152344194d · https://www.cancer.gov/publications/dictionaries/cancer-drug/def/iobenguane-i-131

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Iobenguane PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Iobenguane Permitted Daily Exposure (PDE) report (the Iobenguane PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Iobenguane Occupational Exposure Limit (OEL) report (the Iobenguane OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.